Abstract
To investigate the interaction between alprazolam and caffeine, performance on a differential reinforcement of low-rate behavior schedule and the respective pharmacokinetics (PK) were explored in concurrent studies. Alprazolam PK was not altered by caffeine, but alprazolam retarded caffeine absorption indirectly, as inferred by the lack of i.v. drug administration PK interaction, thereby decreasing serum methylxanthine concentrations. Inasmuch as alprazolam was more potent and short-lived than caffeine in decreasing the reinforcement rate (consonant with their respective t1/2 values, 0.44 and 3.1 hr), the alprazolam/caffeine potency ratio decreased across the session time, which determined the expression of the combined effects. Thus, the decreased methylxanthine level yielded slightly less disruption in performance for the observed combined effect, compared to the expected calculated effect, only near the end of a session. The interaction was PK linked and mainly not distinguishable from independence as indicated by the Pöch dose-response curve method and the integration of PK and pharmacodynamics. The sigmoid maximal effect-link pharmacodynamic model indicated that caffeine did not alter the concentration at half of the maximal effect value of alprazolam and suggested that the interaction is not competitive, but independent. Although the nature of the benzodiazepine-methylxanthine interaction has been controversial in other behavioral studies, as is the role of PK in determining behavior, this and our previous study make it evident that the interaction is independent not only across doses and routes of administration, but also with respect to two indices of differential reinforcement of low rate performance.
Footnotes
-
Send reprint requests to: Dr. Chyan E. Lau, Department of Psychology, Busch Campus, Rutgers University, New Brunswick, NJ 08903.
-
↵1 This work was supported by Grants R 37 # DA03117 and K05 DA00142 from the National Institute on Drug Abuse.
- Abbreviations:
- AUC
- area under the curve
- AUMC
- area under the first moment curve
- BZ
- benzodiazepine
- Cmax
- the maximum concentration
- Cl
- clearance
- cpt
- compartment
- DMX
- dimethylxanthine
- DRC
- dose-response curve
- DRL
- differential reinforcement of low rate
- E0
- the effect when alprazolam concentration is zero
- Emax
- the maximal effect
- F
- absolute bioavailability
- HPLC
- high performance liquid chromatography
- IC50
- the concentration at half of the maximal effect
- IRT
- inter-response time
- keo
- the rate constant out of the effect compartment
- MX
- methylxanthine
- N
- the slope factor of the sigmoid effect curve
- PB
- percent baseline
- PK
- pharmacokinetics
- PD
- pharmacodynamics
- Tmax
- the time at which Cmax occurred
- Vc
- volume of distribution of the central compartment
- Vss
- volume of distribution at steady state
- Received October 24, 1996.
- Accepted February 20, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|